MARCY L’ETOILE, France & SAN DIEGO — bioMérieux, a world leader in the field of in vitrodiagnostics, and Illumina (Nasdaq: ILMN), a world leader in genomics, announce the launch of bioMérieux EpiSeqTM, an innovative next-generation sequencing (NGS) service dedicated to the epidemiological monitoring and control of healthcare-associated infections. The bioMérieux EpiSeqTM service is the first […]
FREMONT, Calif. — WaferGen Bio-systems, Inc. (Nasdaq:WGBS) today announced the first commercial sale of WaferGen’s ICELL8™ Single-Cell System to a major global pharmaceutical company. The system will enable greater single-cell throughput, and provide key insights to be used in important cancer-related research initiatives. “The first commercial sale of our ICELL8 Single-Cell System is a significant […]
PLEASANTON, Calif. — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced regulatory clearance to finalize acquisition of Kapa Biosystems, Inc. (Kapa), a privately-held company headquartered in Wilmington, Massachusetts, US. Kapa Biosystems is a provider of genomic tools in the life sciences sector that employs proprietary technologies to optimize enzymes for next-generation sequencing (NGS), as well as […]
DAVIS, Calif. and SHENZHEN, China – Arcadia Biosciences, Inc. (Nasdaq:RKDA), an agricultural technology company, and BGI, the world’s largest genomics organization, announced a collaboration to create an extensive rice genetic resource library to advance food crop research and development. Under the agreement, BGI and Arcadia will combine their resources and capabilities to create, sequence and […]
BILLERICA, Mass. —— RainDance Technologies, Inc., a genomics tools company dedicated to simplifying the analysis of complex genetic diseases, and Blood Systems Research Institute (BSRI) today announced a research collaboration to develop blood-based assays and protocols for the precise measurement of the human immunodeficiency virus (HIV) latent reservoir using RainDance’s RainDrop® Digital PCR and ThunderBolts™ […]
Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed a distribution agreement with Lucigen Corp. (Middleton, Wisconsin, USA) for the commercialization of SYGNIS’ proprietary product portfolio in the USA. In particular, Lucigen will focus on the clinical oncology research market where no-bias single cell […]
ST. LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced the PDX NGS Gateway Program, a service designed to enable partner personalized medicine initiatives. PierianDx CEO Ted Briscoe said the NGS Gateway Program was developed in direct response to feedback from customers based on the growth of personalized medicine efforts across the country. […]
SAN DIEGO, CA — Human Longevity Inc. (HLI), the genomics based, informatics driven company, announced today that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions. The San Diego-based company has 14 employees who will join HLI including Cypher CEO and […]
Austin, TX — Bioo Scientific recently launched the NEXTflex™ Small RNA-Seq Kit v3, which improves small RNA analysis by making the library prep protocol completely gel-free or allowing for low-input small RNA library preparation. This kit also reduces the biases associated with small RNA sequencing by using patent pending randomized adapter technology, resulting in small […]
LEXINGTON, Mass. – N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced that it has signed a global agreement with WuXi NextCODE to provide clinical and scientific evidence for delivering the best personalized treatment options based on the results of WuXi NextCODE tumor-normal genome sequence interpretation, which identifies key driver […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
